Vistagen Therapeutics, Inc.
fasedienol
social anxiety disorder
Resolved
7days ago
Phase 2 readout · ~ Jun 30, 2026 estimated
What's at stake
Phase 2 trial results for fasedienol in social anxiety disorder are due ~ Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 16h ago
“topline results for the randomized portion of PALISADE-4 are expected in the second quarter of 2026”